Consistently with these data, the screening carried out by Musolino et al detected 10 BRCA1 mutations: seven of the eight IHC evaluated BRCA1-related tumours had a triple negative phenotype (87%) and all were negative for HER2 expression [25]. The gene discussed is BRCA1; the disease is neoplasm.